Related Experiment Video
Updated: Jun 27, 2026
12:00
Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro
Published on: July 5, 2017
Green Tea Polyphenol (-)-Epigallocatechin-3-gallate Protects Endothelial Barrier Function via Myosin Phosphatase and
Rio Wakasugi1, Ayana Shiraki1, Ryohei Mitsui2
1Graduate School of Pharmacy, Ritsumeikan University, 1-1-1 Noji Higashi, Kusatsu, Shiga 525-8577, Japan.
International Journal of Molecular Sciences
|June 26, 2026
Summary
(-)-epigallocatechin-3-gallate (EGCG), a green tea catechin, preserves vascular endothelial barrier integrity. EGCG suppresses signaling pathways that increase endothelial permeability, protecting against vascular dysfunction.
Area of Science:
- Biochemistry
- Cell Biology
- Physiology
Background:
- Vascular endothelial cells form a selective barrier crucial for homeostasis.
- Endothelial barrier dysfunction is linked to various diseases, but protective mechanisms are not fully understood.
- Thrombin increases endothelial permeability by inhibiting myosin phosphatase, leading to increased myosin light chain (MLC) phosphorylation.
Purpose of the Study:
- To investigate the protective effects of (-)-epigallocatechin-3-gallate (EGCG) on endothelial barrier function.
- To elucidate the molecular mechanisms by which EGCG modulates Rho-kinase signaling and endothelial permeability.
Main Methods:
- Endothelial cells were treated with thrombin and/or EGCG.
- Western blotting was used to assess protein phosphorylation levels (MYPT1, MLC).
- Immunofluorescence microscopy was employed to visualize stress fiber formation and VE-cadherin localization.
Main Results:
- EGCG reduced inhibitory phosphorylation of MYPT1, a myosin phosphatase subunit.
- EGCG suppressed Rho-kinase signaling and decreased MLC phosphorylation.
- EGCG inhibited thrombin-induced radial stress fiber formation and preserved VE-cadherin-mediated cell-cell adhesion.
Conclusions:
- EGCG protects endothelial barrier integrity by inhibiting Rho-kinase signaling.
- EGCG's mechanism involves reducing MYPT1 phosphorylation and MLC phosphorylation.
- EGCG represents a potential therapeutic agent for conditions involving endothelial barrier dysfunction.
